One of the two Russian COVID-19 drugs that the Ministry of Health has authorized for sale in pharmacies will cost 12,000 rubles
The Russian anti-coronavirus drug Areplivir, which is now approved for outpatient use, will retail for 12,320 rubles per package . This was reported to TASS by the head of the drug manufacturer Promomed, Andrei Mladentsev. According to him, the retail price should be the same as the price for government supplies. Earlier, Promomed reported that Areplivir could appear in Russian pharmacies on September 21. It will be sold by prescription.